Education
About Us
Working with TipRanks
Follow Us
Nanosonics Limited (AU:NAN)
ASX:NAN
NAN Stock Chart & Stats
AU$3.83
AU$0.07(2.30%)
At close: 4:00 PM EST
AU$3.83
AU$0.07(2.30%)
Day’s Range― - ―
52-Week RangeAU$3.45 - AU$5.18
Previous CloseN/A
Volume330.71K
Average Volume (3M)506.11K
Market Cap
AU$1.09B
Enterprise ValueAU$938.44M
Total Cash (Recent Filing)AU$161.29M
Total Debt (Recent Filing)AU$7.69M
Price to Earnings (P/E)52.9
Beta0.45
Next Earnings
Feb 24, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding303,346,040
10 Day Avg. Volume525,818
30 Day Avg. Volume506,110
Financial Highlights & Ratios
PEG Ratio0.95
Price to Book (P/B)5.85
Price to Sales (P/S)6.18
P/FCF Ratio34.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$4.72Price Target Upside23.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Consumables RevenueA 20% increase in recurring consumables and service revenue implies durable, usage-linked cash flows tied to installed trophon units. This razor-and-blades model creates predictable high-margin repeat revenue, supports long-term margin stability, funds R&D and regional expansion, and reduces revenue cyclicality.
High Gross MarginSustained gross margins above 75% reflect strong product economics from proprietary consumables and platform differentiation. High unit economics provide a buffer against input cost pressures, enable reinvestment in product development and commercialization, and support margin resilience over the medium term.
Strong Balance Sheet & Cash GenerationVery low leverage and a strong equity base, combined with improved free cash flow growth (~27.9%) and efficient operating cash conversion, give the company financial flexibility. This supports continued capex for manufacturing, funding of innovation, and insulation against cyclical downturns or tariff shocks.
Bears Say
Tariff-Related Margin PressurePersistent tariff headwinds represent a structural cost increase that can erode the company's high gross margin if not fully offset by pricing or sourcing changes. Sustained tariffs could force permanent price adjustments, reduce consumable affordability in some markets, and pressure margin-backed investments.
Slow Growth In Japan (APAC Headwind)Lagging uptake in Japan, a material developed-market opportunity, constrains installed-base expansion and recurring consumable volumes in APAC. Structural channel, regulatory, or adoption barriers in Japan could limit medium-term addressable market growth and dampen regional revenue momentum.
Rising Operating Expenses From InvestmentsInvestments in R&D, ERP systems and expanded manufacturing raise operating costs materially. While targeted at long-term growth, higher fixed costs require sustained revenue trajectory to maintain profit margins; slower-than-expected revenue could compress profitability and cash conversion in the medium term.
Nanosonics Limited News
NAN FAQ
What was Nanosonics Limited’s price range in the past 12 months?
Nanosonics Limited lowest share price was AU$3.44 and its highest was AU$5.18 in the past 12 months.
What is Nanosonics Limited’s market cap?
Nanosonics Limited’s market cap is AU$1.09B.
When is Nanosonics Limited’s upcoming earnings report date?
Nanosonics Limited’s upcoming earnings report date is Feb 24, 2026 which is in 5 days.
How were Nanosonics Limited’s earnings last quarter?
Nanosonics Limited released its earnings results on Aug 25, 2025. The company reported AU$0.034 earnings per share for the quarter, beating the consensus estimate of AU$0.03 by AU$0.004.
Is Nanosonics Limited overvalued?
According to Wall Street analysts Nanosonics Limited’s price is currently Undervalued.
Does Nanosonics Limited pay dividends?
Nanosonics Limited does not currently pay dividends.
What is Nanosonics Limited’s EPS estimate?
Nanosonics Limited’s EPS estimate is 0.03.
How many shares outstanding does Nanosonics Limited have?
Nanosonics Limited has 303,346,040 shares outstanding.
What happened to Nanosonics Limited’s price movement after its last earnings report?
Nanosonics Limited reported an EPS of AU$0.034 in its last earnings report, beating expectations of AU$0.03. Following the earnings report the stock price went up 15.085%.
Which hedge fund is a major shareholder of Nanosonics Limited?
Currently, no hedge funds are holding shares in AU:NAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nanosonics Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$4.72 (23.11% Upside)
AU$4.72 (23.11% Upside)
Blogger Sentiment
Bullish
AU:NAN Sentiment 75%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
49.48%
12-Months-Change
Fundamentals
Return on Equity
10.32%
Trailing 12-Months
Asset Growth
11.93%
Trailing 12-Months
Company Description
Nanosonics Limited
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
NAN Stock 12 Month Forecast
Average Price Target
AU$4.72
▲(23.11% Upside)
Technical Analysis
SDI Limited
―
Austco Healthcare Limited
―
Cyclopharm Limited
―
Trajan Group Holdings Ltd
―
Aroa Biosurgery Ltd
―
Options Prices
Currently, No data available
---